重组链激酶对前壁及广泛前壁心肌梗死患者溶栓前后心脏功能的影响 |
| |
引用本文: | 包吉日木图,王洪军,于影,巴金华,赵明. 重组链激酶对前壁及广泛前壁心肌梗死患者溶栓前后心脏功能的影响[J]. 中国心血管病研究杂志, 2009, 7(11): 853-855 |
| |
作者姓名: | 包吉日木图 王洪军 于影 巴金华 赵明 |
| |
作者单位: | 内蒙古民族大学附属医院心血管内科,通辽市,028000 |
| |
摘 要: | 目的通过容量负荷试验评价重组链激酶对急性心肌梗死(AMI)患者溶栓前、后心脏功能的影响。方法选择17例急性前壁及广泛前壁AMI患者进行重组链激酶溶栓,溶栓前、后24h内行漂浮导管连续监测,进行溶栓前后的比较。结果与溶栓前比较,重组链激酶溶栓后6h心功能明显改善,平均肺动脉压由(3.87±0.61)kPa下降至(3.61±0.59)kPa(P〈0.01),肺嵌压由(2.81±0.34)kPa下降至(2.67±0.42)kPa(P〈0.01),心脏指数由2.52±0.49升高至2.72±0.47(P〈0.01)。结论应用重组链激酶溶栓可明显改善AMI患者的心功能。
|
关 键 词: | 重组链激酶 心肌梗死 溶栓治疗 心脏功能试验 |
Effect of recombinant streptokinase thrombolytic therapy on cardiac function in patients with AMI |
| |
Affiliation: | BAO Ji-ri-mu-tu, WANG Hong-jun, YU Ying, et al. (Inner-Mongolia National University Hospital,Tongliao 028000, China) |
| |
Abstract: | Objective To assess the effect of the recombinant streptokinase (r-sk) thrombolytic therapy on cardiac function in patients with AMI. Methods Hemodynamic monitoring was performed immediately at the time of hospital admission and 24 hours after the r-sk thrombolytic treatment on seventeen patients with anterior wall AMI. Results At 6 hours after the r-sk thrombolytic therapy MPAP decreased from (3.87±0.61)kPa to (3.61±0.59)kPa (P〈0.01) and PCWP decreased from (2.81±0.34)kPa to (2.67±0.42)kPa(P〈0.01), CI enhanced from 2.52±0.49 to 2.72±0.47 (P〈0.01). Conclusion The date shows the recombinant streptokinase (r-sk) throm-bolytic therapy significantly improves cardiac function. |
| |
Keywords: | Recombinant streptokinase Myocardial infarction Cardiac function Thrombolytic therapy |
本文献已被 维普 万方数据 等数据库收录! |
| 点击此处可从《中国心血管病研究杂志》浏览原始摘要信息 |
|
点击此处可从《中国心血管病研究杂志》下载全文 |